<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article article-type="research-article"><?properties open_access?><!-- Original-type: ra--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">10471046</article-id><article-id pub-id-type="pmc">2363155</article-id><article-id pub-id-type="pii">6690627</article-id><article-id pub-id-type="doi">10.1038/sj.bjc.6690627</article-id><article-categories><subj-group subj-group-type="heading"><subject>Regular Article</subject></subj-group></article-categories><title-group><article-title>Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hong</surname><given-names>R L</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sheen</surname><given-names>T S</given-names></name><xref ref-type="aff" rid="aff1">2</xref></contrib><contrib contrib-type="author"><name><surname>Ko</surname><given-names>J Y</given-names></name><xref ref-type="aff" rid="aff1">2</xref></contrib><contrib contrib-type="author"><name><surname>Hsu</surname><given-names>M M</given-names></name><xref ref-type="aff" rid="aff1">2</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>C C</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ting</surname><given-names>L L</given-names></name><xref ref-type="aff" rid="aff1">3</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Departments of Oncology, <label>2</label>Otolaryngology and <label>3</label>Radiation Therapy, National Taiwan University Hospital, National Taiwan University, No. 7 Chung-Shan South Road, Taipei, 10016, Taiwan</aff><pub-date pub-type="ppub"><month>08</month><year>1999</year></pub-date><volume>80</volume><issue>12</issue><fpage>1962</fpage><lpage>1967</lpage><history><date date-type="received"><day>15</day><month>10</month><year>1998</year></date><date date-type="rev-recd"><day>04</day><month>02</month><year>1999</year></date><date date-type="accepted"><day>20</day><month>02</month><year>1999</year></date></history><copyright-statement>Copyright 1999, Cancer Research Campaign</copyright-statement><copyright-year>1999</copyright-year><permissions><copyright-holder>Cancer Research Campaign</copyright-holder></permissions><kwd-group><kwd>nasopharyngeal carcinoma</kwd><kwd>metastasis</kwd><kwd>chemotherapy</kwd><kwd>mitomycin</kwd><kwd>cisplatin</kwd></kwd-group></article-meta></front></article>


